Last updated: April 24, 2024
Sponsor: Walailak University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Eye Disorders/infections
Eye Disease
Vision Loss
Treatment
Argos (Alcon Laboratories, Inc.)
IOLMaster 700 (Carl Zeiss Meditec AG)
Clinical Study ID
NCT06377007
WU66290
WU66290
Ages 50-85 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
• Patients with cataract and/or presbyopia who will undergo intraocular lens implantation.
Exclusion
Exclusion Criteria:
- Central corneal thickness less than 490 mm or greater than 600 mm
- Contact lens use within 2 months of cataract surgery
- Severe dry eye
- Corneal or retinal disease affecting visual outcome
- Corneal astigmatism greater than 1.00 D
- Prior corneal refractive surgery
- Dense cataract that does not allow measurements to be taken with an optical biometricssystem.
Study Design
Total Participants: 142
Treatment Group(s): 2
Primary Treatment: Argos (Alcon Laboratories, Inc.)
Phase:
Study Start date:
January 01, 2024
Estimated Completion Date:
December 30, 2025
Study Description
Connect with a study center
Walailak University
Nakhon Si Thammarat, 80160
ThailandActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.